Literature DB >> 26279446

Lgr5-Positive Cells are Cancer-Stem-Cell-Like Cells in Gastric Cancer.

Zhongli Wang1, Chao Liu.   

Abstract

BACKGROUND/AIMS: Effective treatment of gastric cancer (GC) requires better understanding of the molecular regulation of its carcinogenesis. Identification of cancer stem cells (CSCs) in GC appears to be a critical question.
METHODS: We analyzed Lgr5 expression in GC specimen. We used an adeno-associated virus (AAV) that carries diphtheria toxin fragment A (DTA) under the control of Lgr5 promoter (AAV-pLgr5-DTA) to transduce human GC cells. The growth of GC cells with/without depletion of Lgr5-positive cells was studied in vitro in an MTT assay, and in vivo by analyzing bioluminescence levels.
RESULTS: A portion of GC cells in the resected specimen expressed Lgr5. GC cells that formed tumor spheres expressed high Lgr5. Selective depletion of Lgr5-positive GC cells resulted in significant growth inhibition of GC cells in vitro and in vivo.
CONCLUSION: Lgr5-positive cells may be CSCs-like cells in GC and may play a pivotal role in the tumorigenesis of GC. Treating Lgr5-positive GC cells may substantially improve the therapeutic outcome.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26279446     DOI: 10.1159/000430205

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  8 in total

1.  Logarithmic expansion of LGR5+ cells in human colorectal cancer.

Authors:  Maria Laura Martin; Zhaoshi Zeng; Mohammad Adileh; Adrian Jacobo; Christy Li; Efsevia Vakiani; Guoqiang Hua; Lixing Zhang; Adriana Haimovitz-Friedman; Zvi Fuks; Richard Kolesnick; Philip B Paty
Journal:  Cell Signal       Date:  2017-09-25       Impact factor: 4.315

2.  A tumour-resident Lgr5+ stem-cell-like pool drives the establishment and progression of advanced gastric cancers.

Authors:  A Fatehullah; Y Terakado; S Sagiraju; T L Tan; T Sheng; S H Tan; K Murakami; Y Swathi; N Ang; R Rajarethinam; T Ming; P Tan; B Lee; N Barker
Journal:  Nat Cell Biol       Date:  2021-12-02       Impact factor: 28.824

3.  Resveratrol Analog 4-Bromo-Resveratrol Inhibits Gastric Cancer Stemness through the SIRT3-c-Jun N-Terminal Kinase Signaling Pathway.

Authors:  Yun-Shen Tai; Yi-Shih Ma; Chun-Lin Chen; Hsin-Yi Tsai; Chin-Chuan Tsai; Meng-Chieh Wu; Chih-Yi Chen; Ming-Wei Lin
Journal:  Curr Issues Mol Biol       Date:  2021-12-22       Impact factor: 2.976

4.  Dipeptide γ-secretase inhibitor treatment enhances the anti-tumor effects of cisplatin against gastric cancer by suppressing cancer stem cell properties.

Authors:  Ryo Kato; Masaya Iwamuro; Hidenori Shiraha; Shigeru Horiguchi; Emi Tanaka; Ken Matsumoto; Atsushi Ohyama; Hiroaki Sawahara; Teruya Nagahara; Daisuke Uchida; Koichiro Tsutsumi; Hiroyuki Okada
Journal:  Oncol Lett       Date:  2018-08-13       Impact factor: 2.967

Review 5.  A unified model of the hierarchical and stochastic theories of gastric cancer.

Authors:  Yanjing Song; Yao Wang; Chuan Tong; Hongqing Xi; Xudong Zhao; Yi Wang; Lin Chen
Journal:  Br J Cancer       Date:  2017-03-16       Impact factor: 7.640

6.  Identification of AQP3 and CD24 as biomarkers for carcinogenesis of gastric intestinal metaplasia.

Authors:  Haijian Zhao; Jianfei Wen; Xuqiang Dong; Ruji He; Cheng Gao; Weiming Zhang; Zhihong Zhang; Lizong Shen
Journal:  Oncotarget       Date:  2017-06-28

7.  LGR5 overexpression confers poor relapse-free survival in breast cancer patients.

Authors:  Ming-Feng Hou; Po-Ming Chen; Pei-Yi Chu
Journal:  BMC Cancer       Date:  2018-02-22       Impact factor: 4.430

Review 8.  Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.

Authors:  Jian-Peng Gao; Wei Xu; Wen-Tao Liu; Min Yan; Zheng-Gang Zhu
Journal:  World J Gastroenterol       Date:  2018-06-28       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.